Tripleize Co.,Ltd. (5026.T)
JPY 1155.0
(-1.45%)
JPY 1155.0
(-1.45%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 2.57 Million | -241.26 Million | 34.06 Million | 164.41 Million | -134.89 Million |
| Net Income | 83.64 Million | -801.87 Million | 105.97 Million | 61.87 Million | -259.58 Million |
| Depreciation & Amortization | 153.46 Million | 20.62 Million | 32.83 Million | 18.94 Million | 15.69 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -90.28 Million | -36.1 Million | -39.46 Million | -70.65 Million | 26.73 Million |
| Other non-cash items | -144.24 Million | 121.08 Million | -23.62 Million | 58.89 Million | -23.15 Million |
| Investing Cash Flow | -1.07 Billion | -399.6 Million | -192.92 Million | -126.28 Million | -137.04 Million |
| Investments in PPE | -19.81 Million | -146.5 Million | -205.42 Million | -134.4 Million | -126.29 Million |
| Acquisitions | -1.09 Billion | - | - | - | -17.21 Million |
| Investment purchases | -17.17 Million | -252.94 Million | -60 Thousand | -853 Thousand | -1.43 Million |
| Sales/Maturities of investments | 53.28 Million | - | 11.25 Million | 7.81 Million | 8.09 Million |
| Other Investing Activities | -67 Thousand | -164 Thousand | 1.3 Million | 1.15 Million | 6.46 Million |
| Financing Cash Flow | 771.57 Million | 1.31 Billion | 621.14 Million | 28.79 Million | 539.86 Million |
| Debt repayment | -331.44 Million | -1.31 Billion | -26.2 Million | -28.79 Million | -137.3 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -1.8 Million | -504 Thousand | - | - | - |
| Common Stock Issuance | 441.94 Million | 280 Thousand | 601.44 Million | - | 402.56 Million |
| Other Financing Activities | - | -1000.00 | -1000.00 | -1000.00 | - |
| Accounts receivables | -75.83 Million | 21 Million | -28 Million | -128.76 Million | 46.94 Million |
| Accounts payables | -19.58 Million | -64.07 Million | -26.09 Million | 65.12 Million | -5.84 Million |
| Inventory | -53.58 Million | -10.05 Million | 25.68 Million | -9.75 Million | -22.08 Million |
| Other working capital | 58.71 Million | 108 Million | -35 Million | 62.41 Million | -10.07 Million |
| Cash at beginning of period | 1.75 Billion | 1.07 Billion | 617.61 Million | 550.67 Million | 282.73 Million |
| Cash at end of period | 1.61 Billion | 1.75 Billion | 1.07 Billion | 617.61 Million | 550.67 Million |
| Capital Expenditure | -19.81 Million | -146.5 Million | -205.42 Million | -134.4 Million | -126.29 Million |
| Effect of forex changes on cash | - | - | 32 Thousand | 17 Thousand | 15 Thousand |
| Net cash flow / Change in cash | -140.64 Million | 674.63 Million | 462.31 Million | 66.94 Million | 267.93 Million |
| Free Cash Flow | -17.23 Million | -387.77 Million | -171.35 Million | 30 Million | -261.18 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 13 Million | 54 Million | -25 Million | -801.87 Million | -357 Million | -67 Million |
| Depreciation & Amortization | - | - | - | 20.62 Million | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -36.1 Million | - | - |
| Other non-cash items | -13 Million | -54 Million | 25 Million | 121.08 Million | 357 Million | 67 Million |
| Investing Cash Flow | - | - | - | -399.6 Million | - | - |
| Investments in PPE | - | - | - | -146.5 Million | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -252.94 Million | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -164 Thousand | - | - |
| Financing Cash Flow | - | - | - | 1.31 Billion | - | - |
| Debt repayment | - | - | - | -1.31 Billion | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -504 Thousand | - | - |
| Common Stock Issuance | - | - | - | 280 Thousand | - | - |
| Other Financing Activities | - | - | - | -1000.00 | - | - |
| Accounts receivables | - | - | - | 21 Million | - | - |
| Accounts payables | - | - | - | -64.07 Million | - | - |
| Inventory | - | - | - | -10.05 Million | - | - |
| Other working capital | - | - | - | 108 Million | - | - |
| Cash at beginning of period | - | - | - | 1.07 Billion | - | - |
| Cash at end of period | - | - | - | 1.75 Billion | - | - |
| Capital Expenditure | - | - | - | -146.5 Million | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | 674.63 Million | - | - |
| Free Cash Flow | - | - | - | -387.77 Million | - | - |
NNN1
CHEMOPH
TUP
WHLRL
7426
BNVIF